Benefits
General Digestive Comfort
Supplemental peptidase enzymes add extra protein-breaking activity to a high-protein meal on top of what the stomach and pancreas already produce. The idea that this reduces post-meal bloating, heaviness or discomfort is plausible from the mechanism but untested here: neither reference on this page measured digestive comfort, or any other outcome, in people.
Gluten Peptide Breakdown Support
In test tubes and simulated stomach models, prolyl endopeptidases from Aspergillus species can break apart the proline-rich pieces of gluten that human digestive enzymes struggle with. That laboratory activity is the reason these blends are marketed to people avoiding gluten, but it is not evidence of protection. These enzymes do not make gluten safe for people with celiac disease or non-celiac gluten sensitivity, they have never been shown to prevent intestinal damage, and no one should treat an enzyme product as permission to eat gluten. The most that can honestly be said is that they may help break down small amounts of incidental gluten during digestion.
Casein and Dairy Peptide Digestion
DPP-IV and related enzymes can break down beta-casomorphin and similar peptides from dairy protein in laboratory work. Reports of feeling better when taking peptidase with dairy are anecdotal, and no study cited on this page tested dairy digestion or dairy symptoms in people. An enzyme supplement does not treat a milk allergy, and peptidase is not lactase, so it does nothing for lactose intolerance.
Plant Protein Digestibility
Plant proteins from peas, lentils and beans contain compounds that slow protein digestion, and added enzymes can act on such proteins in laboratory conditions. Whether this improves amino acid availability or reduces bloating after a plant-protein meal has not been tested in people in any study cited on this page.
Mechanism of action
Endopeptidase Cleavage Activity
Fungal endopeptidases cleave internal peptide bonds in dietary proteins, producing shorter peptides accessible to brush-border peptidases. This complements endogenous pepsin and pancreatic protease activity, particularly during high-protein meals.
Prolyl Bond Hydrolysis (AN-PEP)
Aspergillus niger prolyl endopeptidase specifically cleaves peptide bonds C-terminal to proline residues — bonds that are resistant to human gastric and pancreatic proteases. This is why AN-PEP is used in gluten-targeted products, although cutting these bonds in laboratory conditions is not the same as protecting a person who eats gluten.
DPP-IV Exopeptidase Activity
Dipeptidyl peptidase IV cleaves dipeptides from the N-terminus of peptides containing proline or alanine in the penultimate position. In laboratory conditions this enzyme degrades peptides such as beta-casomorphin-7 from casein and similar fragments from gluten. How completely it does so inside a real meal in a real person has not been measured in the research cited here.
Gastric pH Compatibility
Fungal proteases — unlike many bacterial enzymes — retain activity across a broad pH range (~2-7), allowing them to begin working in the acidic stomach and continue in the duodenum. This pH flexibility makes them practical oral supplements.
Clinical trials
Production and biochemical characterization of two major secreted prolyl endopeptidases (AoS28A, AoS28B) from Aspergillus oryzae, with in vitro evaluation of their ability to degrade proline-rich gluten peptides under simulated gastric conditions. (Eugster et al, Microbiology)
In vitro enzyme characterization with gluten peptide substrates.
Both enzymes broke down proline-rich gluten fragments in the test tube at stomach-like acidity, with activity similar to the AN-PEP enzyme from Aspergillus niger. This is laboratory biochemistry with no people involved. It shows the enzymes act on gluten peptides in a tube and says nothing about symptoms, intestinal damage or safety in anyone who eats gluten.
Review of pharmacological strategies for managing celiac disease, including enzyme therapy approaches using prolyl endopeptidases to degrade gluten. (McCarville et al, Curr Opin Pharmacol)
Narrative review of mechanisms and trials.
This is a review of experimental drug development for celiac disease, a serious autoimmune condition, not a study of a dietary supplement. It surveys enzyme strategies among other approaches and is clear that enzymes are not a substitute for the gluten-free diet. It is included here as background only. No human trial of a peptidase supplement is cited anywhere on this page.